CANbridge Pharmaceuticals revenue up 25.6% but net loss RMB37.1M
CANbridge Pharmaceuticals reported revenue up 25.6% and a net loss of RMB37.1M, with strategic investment and going-concern risks noted.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.